Global COVID-19 Deaths On Track To Top 1 Million, UK Prepares New 'Localized Lockdown' Measures: Live Updates
Stocks Recover while the Greenback Consolidates
Aquestive Plunges 37% As FDA Rejects Seizure Drug; Street Stays Bullish
Blueprint Nabs EU Green Light For Gastro Cancer Treatment
Roche Inks €380M Inflazome Deal, Boosting Inflammation Pipeline
Gilead’s Filgotinib Arthritis Drug Scores Europe, Japan Approval
Last-resort life support option helped majority of critically ill COVID-19 patients survive
Vertex or Galapagos: Which Biotech Stock Does The Street Favor?
Macro as September Winds Down
Lessons On Inflation From The Past
FDA Approves Nucala as First Biologic Treatment for HES
Week Ahead – Let the debates begin!
Japanese researchers trial early warning test for acute Covid-19 cases
S&P Futures, Global Stocks Slump As European Banks Crash To All-Time Low
Lots of noise, not much substance
Abenomics: Big Debts with Nothing to Show for It
UK, France Suffer Record Jump In COVID-19 Cases As New York Hospitals Report Alarming Spike: Live Updates
Traders On Edge As Futures Fail To Rebound After Wednesday Rout
Japanese Yen Remains Soft Despite Pessimistic Mood
Asia follows Wall Street south
Japanese Yen Mixed amid Signs of Economic Slowdown
Fujifilm’s Avigan shown to be effective in Japanese Phase 3 trial for Covid-19
Fujifilm’s Avigan shown to be effective in Japanese Phase-3 trial for Covid-19
Faulty transportation of messenger RNA is the culprit in ALS
US COVID-19 Cases Near 7 Million As NYC Warns Of New 'Hot Spots' In Brooklyn, Queens: Live Updates
Fiscal Sustainability And The Fiscal Folk Theorem
Futures Extend Rebound As Nike Soars, Tesla Tumbles; Powell On Deck For 2nd Day
Macro Briefing: 23 September 2020
A mixed start for Asian equity markets
Nikko set to list Japan’s cheapest Nasdaq 100 ETFs